Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non–Small-Cell Lung Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non–Small-Cell Lung Cancer
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 32, Issue 34, Pages 3824-3830
Publisher
American Society of Clinical Oncology (ASCO)
Online
2014-10-28
DOI
10.1200/jco.2014.56.7412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib
- (2014) Gregory N. Gan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Treatment of Stage IV Non-small Cell Lung Cancer
- (2013) Mark A. Socinski et al. CHEST
- Maintenance Therapy for Advanced Lung Cancer: Who, What, and When?
- (2013) David E. Gerber JOURNAL OF CLINICAL ONCOLOGY
- Surgical management of adrenal metastases
- (2013) Ciarán T. Bradley et al. JOURNAL OF SURGICAL ONCOLOGY
- Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature
- (2013) Allison Ashworth et al. LUNG CANCER
- Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): Patient outcomes and prognostic factors
- (2013) Gwendolyn H.M.J. Griffioen et al. LUNG CANCER
- Oligometastases: the new paradigm and options for radiotherapy
- (2013) H. Badakhshi et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Stereotactic Body Radiation Therapy for Treatment of Primary and Metastatic Pulmonary Malignancies
- (2013) Chris R. Kelsey et al. Surgical Oncology Clinics of North America
- Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
- (2012) David A Palma et al. BMC CANCER
- Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
- (2012) Andrew J. Weickhardt et al. Journal of Thoracic Oncology
- Stereotactic body radiotherapy for oligometastases
- (2012) Alison C Tree et al. LANCET ONCOLOGY
- Stereotactic body radiotherapy treatment of extracranial metastases
- (2012) Joseph K. Salama et al. Nature Reviews Clinical Oncology
- Management of Non-Small Cell Lung Cancer with Oligometastasis
- (2012) Liza C. Villaruz et al. Current Oncology Reports
- Noninferiority Trials in Second-Line Treatments of Nonsmall Cell Lung Cancer
- (2011) Davide Tassinari et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Third CECOG consensus on the systemic treatment of non-small-cell lung cancer
- (2011) T. Brodowicz et al. ANNALS OF ONCOLOGY
- Stereotactic body radiotherapy for multisite extracranial oligometastases
- (2011) Joseph K. Salama et al. CANCER
- Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?
- (2011) Antonio Passaro et al. Expert Review of Anticancer Therapy
- Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study
- (2011) Michael T. Milano et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer
- (2011) Michael D. Hasselle et al. Journal of Thoracic Oncology
- Surgical Treatment of Hepatic Colorectal Metastasis
- (2010) Kaori Ito et al. CANCER JOURNAL
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- (2010) Robert Timmerman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis
- (2009) Kyle E. Rusthoven et al. ACTA ONCOLOGICA
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
- (2009) Kyle E. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
- (2009) Kyle E. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic body radiation therapy: a novel treatment modality
- (2009) Simon S. Lo et al. Nature Reviews Clinical Oncology
- Universal Survival Curve and Single Fraction Equivalent Dose: Useful Tools in Understanding Potency of Ablative Radiotherapy
- (2008) Clint Park et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Analysis of Patients With Oligometastases Undergoing Two or More Curative-Intent Stereotactic Radiotherapy Courses
- (2008) Michael T. Milano et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions
- (2008) S. Ramalingam et al. ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started